Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:cangrelor
|
| gptkbp:approvedBy |
gptkb:European_Union
|
| gptkbp:ATCCode |
B01AC27
|
| https://www.w3.org/2000/01/rdf-schema#label |
Kengrexal
|
| gptkbp:indication |
patients undergoing percutaneous coronary intervention
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:The_Medicines_Company
|
| gptkbp:mechanismOfAction |
P2Y12 receptor antagonist
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:usedFor |
prevention of thrombotic events
|
| gptkbp:bfsParent |
gptkb:AR-C
|
| gptkbp:bfsLayer |
6
|